(Q33418451)

English

Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

0 references

1 reference

Europe PubMed Central

Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis (English)

1 reference

Europe PubMed Central

26 July 2017

methicillin-resistant Staphylococcus aureus

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

object named as

Yan Wang

1

0 references

object named as

Jiao Xie

3

0 references

author name string

Yamin Zou

2

1 reference

Europe PubMed Central

26 July 2017

Taotao Wang

4

1 reference

Europe PubMed Central

26 July 2017

Xiaowei Zheng

5

1 reference

Europe PubMed Central

26 July 2017

Hairong He

6

1 reference

Europe PubMed Central

26 July 2017

Weihua Dong

7

1 reference

Europe PubMed Central

26 July 2017

Jianfeng Xing

8

1 reference

Europe PubMed Central

26 July 2017

Yalin Dong

9

1 reference

Europe PubMed Central

26 July 2017

publication date

30 October 2014

1 reference

Europe PubMed Central

26 July 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

26 July 2017

71

1 reference

Europe PubMed Central

26 July 2017

1

1 reference

Europe PubMed Central

26 July 2017

107-115

1 reference

Europe PubMed Central

26 July 2017

https://scigraph.springernature.com/pub.10.1007/s00228-014-1775-x

0 references

National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

International study of the prevalence and outcomes of infection in intensive care units

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Health care-associated invasive MRSA infections, 2005-2008.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Surveillance of bacterial resistance among isolates in Shanghai in 1999.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Developing optimal search strategies for detecting clinically sound studies in MEDLINE.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid for the treatment of infections caused by Gram-positive pathogens in China

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1775-X

21 January 2018

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25355172

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25355172

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-014-1775-X

1 reference

Europe PubMed Central

26 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33418451&oldid=1783872361"